Approval · Notice of Compliance 2833 · 2003

METADOL-D: Notice of Compliance 2833

Issued July 11, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 2833
Date: July 11, 2003
Company: Pharmascience Inc.Montreal, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: Supplement to a New Drug Submission (SNDS), supplement
Submission class: Other
Reason: New dosage form: 1mg, 5mg, 10mg, 25mg tablets
Therapeutic class: Treatment of opioid dependence

Products in this notice

Brand	DIN	Status today
METADOL-D	02247693	Cancelled Pre Market
METADOL-D	02247695	Cancelled Pre Market
METADOL-D	02247696	Cancelled Pre Market
METADOL-D	02247697	Cancelled Pre Market

Medicinal ingredients

METHADONE HYDROCHLORIDE 1 MG per TAB
METHADONE HYDROCHLORIDE 5 MG per TAB
METHADONE HYDROCHLORIDE 10 MG per TAB
METHADONE HYDROCHLORIDE 25 MG per TAB